Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» InterMune Hits Home Run With Pivotal Lung Drug Study Results
InterMune Hits Home Run With Pivotal Lung Drug Study Results
InterMune Hits Home Run With Pivotal Lung Drug Study Results
Submitted by
admin
on February 25, 2014 - 8:14am
Source:
TheStreet.com
News Tags:
InterMune
pirfenidone
IPF
idiopathic pulmonary fibrosis
Headline:
InterMune Hits Home Run With Pivotal Lung Drug Study Results
Do Not Allow Advertisers to Use My Personal information
